论文部分内容阅读
目的 探讨普米克令舒雾化吸入佐治喘息性支气管炎 (喘支 )的疗效。方法 将 5 4例喘支患儿随机分为两组 ,两组均采用综合治疗 ,观察组加用普米克令舒雾化吸入 ,对治疗前后症状、体征、持续时间、气道阻力参数进行比较。结果 观察组在治愈率、缓解喘息、缩短哮鸣音及咳嗽持续时间、改善肺功能、降低气道阻力的作用均明显优于对照组 (P <0 0 5 )。结论 普米克令舒雾化吸入治疗喘息性支气管炎 ,可缩短病程 ,改善肺功能 ,疗效确切 ,且方便、安全 ,可作为佐治喘支的主要药物
Objective To investigate the therapeutic effect of pulmicort respiration inhalation on asthmatic bronchitis (asthma). Methods Fifty-four children with asthma were randomly divided into two groups. The two groups were treated by combination therapy. The observation group was treated with inhalation of pulmicort respirator, and the parameters of symptoms, signs, duration and airway resistance were compared before and after treatment . Results The observation group was significantly better than the control group in the cure rate, relieving wheezing, shortening wheezing and cough duration, improving lung function and reducing airway resistance (P <0.05). Conclusion Pulmicort respire inhalation therapy for asthmatic bronchitis can shorten the course of disease and improve lung function, and the curative effect is exact, convenient, safe and can be used as the main drug of asthma.